Edition:
India

Healthcare

BORO.BO
CLAI.BO
NOIN.BO

Merck to buy Viralytics for $394 mln to boost immuno-oncology

Feb 21 U.S. drugmaker Merck & Co, already one of the leaders in the hot area of cancer immunotherapy, said on Wednesday it had agreed to buy Viralytics for 502 million Australian dollars ($394 million) to expand its drug pipeline.

2:55pm IST

BRIEF-Merck And Viralytics Announce Acquisition Agreement

* MERCK AND VIRALYTICS ANNOUNCE ACQUISITION AGREEMENT, EXPANDING MERCK'S LEADING IMMUNO-ONCOLOGY PIPELINE

2:43pm IST

BRIEF-Riken Vitamin announces shareholding structure change

* Says its top shareholder Takeda Pharmaceutical Company Limited will cut voting power in the company to 5.4 percent from 12.6 percent, and will become the third biggest shareholder of the company, effective Feb. 27

2:26pm IST

Korea Kolmar buying CJ HealthCare for $1.2 bln; shares soar

* Private equity firms had bid for CJ HealthCare, local paper had said

2:23pm IST

BRIEF-Telemedycyna Polska Prelim. Jan. Revenue Up 12.8 Pct YoY

* REPORTED ON TUESDAY PRELIM JAN. REVENUE OF 412,700 ZLOTYS, UP 12.8 PERCENT YEAR-ON-YEAR

2:20pm IST
BSE OIL & GAS +0.10%
BSE BANKEX +0.13%
BSE METALS -1.75%
BSE REALTY -0.72%
BSE AUTO -0.26%
BSE POWER -0.53%
BSE-CG -0.72%

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Photo

CBI arrests sixth bank official in $1.8 billion PNB fraud case

NEW DELHI The Central Bureau of Investigation (CBI) has arrested a senior official of state-run Punjab National Bank (PNB), the agency said on Wednesday, as an inquiry into a $1.8-billion fraud at the bank expands a week after it unveiled the size of the alleged scam.